Table 2.
Parameter | Cohort 1 f(n=37), n (%) |
Cohort 2 (n=30), n (%) |
Total (N=67), n (%) |
---|---|---|---|
Patients with TEAEs | 13 (35.1) | 9 (30.0) | 22 (32.8) |
Pruritus | 5 (13.5) | 4 (13.3) | 9 (13.4) |
Erythema | 2 (5.4) | 2 (6.7) | 4 (6.0) |
Rash | 3 (8.1) | 0 (0) | 3 (4.5) |
Dermatitis contact | 2 (5.4) | 1 (3.3) | 3 (4.5) |
Rash erythematous | 2 (5.4) | 0 (0) | 2 (3.0) |
Severe TEAEs (rash) | 1 (2.7) | 0 (0) | 1 (1.5) |
Abbreviation: TEAE, treatment-emergent adverse event.